PA Medical News about Obesity

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo
Journal of Clinical Endocrinology and Metabolism, 10/29/09

Greenway FL et al. – NB caused gradual sustained weight loss over 48 wk; NB32 and NB16 demonstrated greater weight loss in the intent–to–treat population due to lower attrition rates. Further study is needed to demonstrate long–term efficacy and safety of NB.

<< Previous
SUNCT Syndrome Successfully Treated with the Combination of...

Next >>
Hearing Acuity as a Predictor of Walking Difficulties in Older...